Literature DB >> 24922662

FIP-gts potentiate autophagic cell death against cisplatin-resistant urothelial cancer cells.

Jian-Ri Li1, Chen-Li Cheng2, Wan-Jung Yang3, Chi-Rei Yang4, Yen-Chuan Ou5, Ming-Ju Wu6, Jiunn-Liang Ko7.   

Abstract

BACKGROUND: Urothelial cancer (UC) is a common cancer among males. Once metastatic or chemoresistant diseases develop, there is little effective treatment available. A fungal immunomodulatory protein, ganoderma tsugae (FIP-gts) possesses antitumor activity against solid tumors and inhibits telomerase activity. FIP-gts induces autophagy in cancer cells and may provide an alternative pathway against chemo-resistance.
MATERIALS AND METHODS: Two UC cell lines were used to investigate the cytotoxicity effects and the autophagy regulation of FIP-gts using flow cytometry, acidic vesicular organelles (AVO) staining and western blotting.
RESULTS: MTT assay showed that FIP-gts and bafilomycin-A1 (Baf-A1) and or chloroquine (CQ) could enhance a significantly synergistic cytotoxicity. The treatment of UC cell lines with FIP-gts activated LC-3 II formation and AVO positive staining on western blot and flow cytometry. Interestingly, FIP-gts and Baf-A1 combined treatment was found to lead to enhancement of apoptosis along with inhibition of autophagy in parental and resistant UC cells.
CONCLUSION: FIP-gts may have the potential to be utilized as a therapeutic adjuvant for the treatment of resistant UC cancer down-regulating Beclin-1 to activate autophagic cell death. Copyright
© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Apoptosis; autophagy; chemo-resistant; urothelial carcinoma

Mesh:

Substances:

Year:  2014        PMID: 24922662

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

Review 1.  Autophagy and urothelial carcinoma of the bladder: A review.

Authors:  Thenappan Chandrasekar; Christopher P Evans
Journal:  Investig Clin Urol       Date:  2016-06-10

2.  FIP-nha, a fungal immunomodulatory protein from Nectria haematococca, induces apoptosis and autophagy in human gastric cancer cells via blocking the EGFR-mediated STAT3/Akt signaling pathway.

Authors:  Shu-Ying Li; Li-Zhen Hou; Ya-Xin Gao; Na-Na Zhang; Bei Fan; Fengzhong Wang
Journal:  Food Chem (Oxf)       Date:  2022-02-25

Review 3.  Ganoderma lucidum: Unutilized natural medicine and promising future solution to emerging diseases in Africa.

Authors:  M A Oke; F J Afolabi; O O Oyeleke; T A Kilani; A R Adeosun; A A Olanbiwoninu; E A Adebayo
Journal:  Front Pharmacol       Date:  2022-08-22       Impact factor: 5.988

Review 4.  Contrast effects of autophagy in the treatment of bladder cancer.

Authors:  Ece Konac; Yener Kurman; Sümer Baltaci
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-20

5.  Calyxin Y sensitizes cisplatin-sensitive and resistant hepatocellular carcinoma cells to cisplatin through apoptotic and autophagic cell death via SCF βTrCP-mediated eEF2K degradation.

Authors:  Chao Zhang; Jian-Li Lei; Hao Zhang; Yuan-Zheng Xia; Pei Yu; Lei Yang; Ling-Yi Kong
Journal:  Oncotarget       Date:  2017-08-03

6.  GMI ablates cancer stemness and cisplatin resistance in oral carcinomas stem cells through IL-6/Stat3 signaling inhibition.

Authors:  Tung Yuan Wang; Cheng-Chia Yu; Pei-Ling Hsieh; Yi-Wen Liao; Chuan-Hang Yu; Ming-Yung Chou
Journal:  Oncotarget       Date:  2017-07-31

Review 7.  Natural Bioactive Compounds from Fungi as Potential Candidates for Protease Inhibitors and Immunomodulators to Apply for Coronaviruses.

Authors:  Nakarin Suwannarach; Jaturong Kumla; Kanaporn Sujarit; Thanawat Pattananandecha; Chalermpong Saenjum; Saisamorn Lumyong
Journal:  Molecules       Date:  2020-04-14       Impact factor: 4.411

8.  Immunomodulatory Protein from Nectria haematococca Induces Apoptosis in Lung Cancer Cells via the P53 Pathway.

Authors:  Jing-Jing Wang; Yan Wang; Lizhen Hou; Fengjiao Xin; Bei Fan; Cong Lu; Lijing Zhang; Fengzhong Wang; Shuying Li
Journal:  Int J Mol Sci       Date:  2019-10-28       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.